Developer docs
API playgroundTry for free, no card

Search company profiles

LongSeq

Full company profile

uuid002s22x

Namestring
LongSeq
Legal namestring
LONGSEQ APPLICATIONS, S.L.
Websiteurl
longseq.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

LongSeq (legal entity LONGSEQ APPLICATIONS, S.L.) is a privately held genetic analysis service provider founded in 2020 and headquartered in Churra, Murcia, Spain. The company is an official service provider of Oxford Nanopore Technologies and operates a 10-product portfolio of long-read nanopore sequencing services spanning whole-genome sequencing (human, plant, animal, bacterial), targeted region sequencing via PCR and enrichment, full-transcript RNA sequencing, 16S metagenomics, de novo assembly, tandem repeat characterisation, plasmid sequencing (Plasmi-seq), a hereditary cancer panel covering 200+ genes (Hereditary-Cancer-Seq), and retrotransposon analysis (RetroSeq). The technical differentiator is the ability to resolve complex genetic cases — structural variants, tandem repeat expansions, retrotransposon insertions, haplotype phasing, and methylation — on unmanipulated native DNA/RNA using MinION, GridION, and PromethION devices, with average read lengths around 10 Kb for whole genomes and approximately 780 bp in RNA sequencing. End-to-end delivery includes project advisory, library preparation, sequencing, and proprietary bioinformatics pipelines bundled into the service, with a 2-4 week sample-to-data turnaround.

The company is structured around an interdisciplinary team drawn from the University of Murcia, IMIB (Instituto Murciano de Investigación Biomédica), and Hospital Morales Meseguer, combining molecular biology, medicine, pharmacology, and computer engineering. Customers include biomedical researchers, the agri-food sector, veterinary researchers, and R&D companies; a documented case study is with the Haematology and Oncology Group at Morales Meseguer Hospital for antithrombin deficiency. Commercial go-to-market is sales-led, quote-based, accessed via the website contact form and a client portal. The company has also developed educational channels (nanopore sequencing courses and workshops) that serve as a top-of-funnel engagement layer. In 2024 it received non-dilutive EU FEDER project funding via INFO Murcia under the RIS4 2021-2027 strategy, and in 2026 it announced a tertiary-analysis integration with SeqOne and collaborations with VarSome, reflecting an ecosystem-buildout strategy around the core Oxford Nanopore platform.

Short descriptiontext

LongSeq is a Murcia, Spain-based nanopore sequencing service provider offering long-read whole-genome, RNA, metagenomic, cancer panel, and retrotransposon analyses to biomedical, veterinary, and agri-food researchers using Oxford Nanopore Technologies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMurcia, Spain
HQ citystring
Murcia
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nanopore sequencing services, long-read genomic analysis, bioinformatics pipelines, hereditary cancer panels, structural variant detection
Industry3 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
SIC code1 code
  • Services-Computer Processing & Data Preparation7374
Product category
Genomic Sequencing Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Sequencing Services
TypeProfessional Services
Description

Comprehensive genetic study, sequencing, and diagnosis services including whole genome sequencing, targeted region sequencing (PCR and enrichment), RNA sequencing, metagenomics, de novo assembly, tandem repeats analysis, plasmid sequencing, hereditary cancer sequencing, and retrotransposon analysis. Pricing is quote-based with payment terms of 30 days and 25% advance payment required for services over 5,000 euros.

longseq.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Professional sequencing services - quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Services priced upon consultation; 25% advance payment for services over 5,000 euros; 30-day payment terms after data delivery

longseq.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

LongSeq is a service provider offering comprehensive nanopore-based genetic sequencing and bioinformatics analysis using Oxford Nanopore Technologies' long-read platform. Services span whole genome sequencing, targeted region analysis (PCR and enrichment), RNA sequencing, metagenomics, de novo assembly, tandem repeat analysis, plasmid sequencing, hereditary cancer panels, and retrotransposon analysis, delivered end-to-end from study design advice to library preparation and data interpretation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Average read length of 10Kb in whole genome sequencing
+3 more records
Product overview1 text field

LongSeq is a comprehensive and personalised nanopore sequencing service provider, built on Oxford Nanopore Technologies' long-read sequencing platform. The company offers a portfolio of 10 core genomic sequencing services spanning whole genome sequencing (Genomic), targeted region analysis via PCR and enrichment, RNA sequencing, metagenomics, de novo assembly, tandem repeat analysis, plasmid sequencing (Plasmi-seq), hereditary cancer panels (Hereditary-Cancer-Seq), and retrotransposon analysis (RetroSeq). Services are delivered through an end-to-end model from sample preparation advice through library preparation to bioinformatics analysis. An add-on tertiary analysis module (LongSeq + SeqOne) integrates SeqOne's AI-powered variant analysis platform for enhanced variant filtering and prioritization.

Product and service7 records
1Genomic (Whole Genome Sequencing)
CategorySequencing Services
Description

Whole genome sequencing service (human, plant, animal, bacterial) using MinION, GridION, or PromethION devices, producing ultra-long reads from unmanipulated material for structural variant characterization, complex variant identification, epigenetic modification detection, and haplotype determination. Targeted at biomedical researchers, clinical researchers, and agricultural/veterinary scientists with cases that short-read sequencing cannot resolve.

2Targeted Region (PCR)
CategorySequencing Services
Description

Sequencing of PCR products without fragmentation, enabling high-depth analysis with multiplexed samples to reduce cost. Applications include biallelic mutation studies, low-frequency SNP analysis, haplotype studies, and CRISPR-Cas9 cleavage evaluation. Targeted at researchers performing targeted genetic studies at high depth.

3Targeted Region (Enrichment)
CategorySequencing Services
Description

Real-time sequencing directed to genomic regions of interest up to 3 Mb without DNA manipulation, achieving greater depth of coverage in the desired region. Supports biallelic mutations, low-frequency SNP analysis, haplotype studies, and population studies. Aimed at researchers needing targeted depth without amplification steps.

4RNA Sequencing
CategorySequencing Services
Description

Direct sequencing of whole transcript reads using ultra-long reads of native RNA or cDNA without fragmentation or amplification. Enables characterization of complete transcripts, splicing variants, fusion genes, new isoforms, epitranscriptomic modifications, antisense transcripts, and lncRNA isoforms. Targeted at researchers requiring full-length transcript analysis.

5Metagenomics 16S
CategorySequencing Services
Description

Complete 16S rRNA gene sequencing enabling accurate identification of closely related species, full transcriptomic analysis of microbial RNA, real-time species identification, microbial resistance, and virulence factor determination. Aimed at veterinary, agri-food, and biomedical researchers studying microbial communities.

6De Novo Assembly
CategorySequencing Services
Description

De novo genome assembly from short reads provided by the client using standard genomic library preparation and a specific computational pipeline. Recommended for small genomes. Targeted at researchers needing reference-free genome assembly for novel organisms.

7Tandem Repeats Analysis
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

LongSeq is an official service provider of Oxford Nanopore Technologies. They use state-of-the-art nanopore sequencing technology capable of solving complex genetic cases. The company uses Oxford Nanopore consumables and devices for all analyses, including MinION, GridION, and PromethION instruments.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

SeqOne is an AI-powered tertiary analysis platform for clinical genomics — LongSeq's announced technology partner (June 2026) for variant interpretation. It is an enabling/ecosystem partner whose platform LongSeq bundles into its service, not a directly competing sequencing service.

TypeBroad incumbent
Description

Eurofins Genomics is a global, scale sequencing services arm of Eurofins Scientific offering Sanger, NGS, and long-read services with broad bioinformatics support. It is a broad incumbent peer operating across the same genomic sequencing space as LongSeq but with much broader geographic reach, menu, and scale.

3Genomics and Bioinformatics Service (IMIB)
TypeRegional player
Description

IMIB (Instituto Murciano de Investigación Biosanitaria) in Murcia operates a sequencing core facility that closely overlaps with LongSeq's institutional roots and customer base. It functions as a regional peer — both serve biomedical researchers around the Murcia region — but on a non-commercial basis.

TypeOthers
Description

Oxford Nanopore Technologies is the platform provider that supplies LongSeq's devices and consumables, while also operating direct-service offerings (e.g., the Oxford Nanopore community of service providers). It is an upstream enabling partner and adjacent commercial actor rather than a direct customer-facing service peer.

TypeDirect peer
Description

SeqCenter is an Oxford Nanopore-promoted, US-based nanopore sequencing services provider offering whole-genome, amplicon, and targeted sequencing. It is a direct peer delivering equivalent ONT-based sequencing services to research customers, differing mainly by serving a US/EU customer base rather than Spain-centric.

6VarSome (Saphetor)
TypeOthers
Description

VarSome (Saphetor) is a clinical genomics variant interpretation platform and a listed LongSeq collaborator. It is an enabling/ecosystem adjacent entity rather than a competing sequencing service, providing the bioinformatics interpretation layer used in LongSeq's hereditary cancer workflow.

TypeDirect peer
Description

Plasmidsaurus is a nanopore sequencing service provider specializing in plasmid verification — the same Plasmi-seq service LongSeq offers. It is a direct peer in the long-read, mid-throughput end of the nanopore services market, targeting similar molecular biology researchers.

TypeDirect peer
Description

FASTERIS is a Swiss DNA sequencing services provider offering Sanger, NGS, and long-read sequencing including nanopore. It is a direct European peer to LongSeq with similar service breadth across genomic and targeted sequencing, and comparable academic/research customer base.

TypeBroad incumbent
Description

Novogene is a global NGS service provider with significant European operations offering WGS, RNA-seq, and custom panels at scale. It is a broad incumbent peer whose commoditized pricing power in standard sequencing services represents LongSeq's main competitive threat.

10CEGAT GmbH
TypeDirect peer
Description

CEGAT is a Tübingen-based sequencing services provider covering targeted panels, exomes, and genomes with clinical-grade certifications. It is a direct European peer to LongSeq in clinical genomics service delivery, with overlapping customer types (hospitals, research groups, rare disease diagnostics).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LongSeq

Genomic Sequencing Serviceslongseq.com

LongSeq is a Murcia, Spain-based nanopore sequencing service provider offering long-read whole-genome, RNA, metagenomic, cancer panel, and retrotransposon analyses to biomedical, veterinary, and agri-food researchers using Oxford Nanopore Technologies.

What LongSeq does

LongSeq (legal entity LONGSEQ APPLICATIONS, S.L.) is a privately held genetic analysis service provider founded in 2020 and headquartered in Churra, Murcia, Spain. The company is an official service provider of Oxford Nanopore Technologies and operates a 10-product portfolio of long-read nanopore sequencing services spanning whole-genome sequencing (human, plant, animal, bacterial), targeted region sequencing via PCR and enrichment, full-transcript RNA sequencing, 16S metagenomics, de novo assembly, tandem repeat characterisation, plasmid sequencing (Plasmi-seq), a hereditary cancer panel covering 200+ genes (Hereditary-Cancer-Seq), and retrotransposon analysis (RetroSeq). The technical differentiator is the ability to resolve complex genetic cases — structural variants, tandem repeat expansions, retrotransposon insertions, haplotype phasing, and methylation — on unmanipulated native DNA/RNA using MinION, GridION, and PromethION devices, with average read lengths around 10 Kb for whole genomes and approximately 780 bp in RNA sequencing. End-to-end delivery includes project advisory, library preparation, sequencing, and proprietary bioinformatics pipelines bundled into the service, with a 2-4 week sample-to-data turnaround.

The company is structured around an interdisciplinary team drawn from the University of Murcia, IMIB (Instituto Murciano de Investigación Biomédica), and Hospital Morales Meseguer, combining molecular biology, medicine, pharmacology, and computer engineering. Customers include biomedical researchers, the agri-food sector, veterinary researchers, and R&D companies; a documented case study is with the Haematology and Oncology Group at Morales Meseguer Hospital for antithrombin deficiency. Commercial go-to-market is sales-led, quote-based, accessed via the website contact form and a client portal. The company has also developed educational channels (nanopore sequencing courses and workshops) that serve as a top-of-funnel engagement layer. In 2024 it received non-dilutive EU FEDER project funding via INFO Murcia under the RIS4 2021-2027 strategy, and in 2026 it announced a tertiary-analysis integration with SeqOne and collaborations with VarSome, reflecting an ecosystem-buildout strategy around the core Oxford Nanopore platform.

LongSeq firmographics

Firmographics
Name
LongSeq
Legal name
LONGSEQ APPLICATIONS, S.L.
Website
https://longseq.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
LongSeq is a Murcia, Spain-based nanopore sequencing service provider offering long-read whole-genome, RNA, metagenomic, cancer panel, and retrotransposon analyses to biomedical, veterinary, and agri-food researchers using Oxford Nanopore Technologies.
Ownership category
akta.pro rank

LongSeq industry classification

Industry
Product category
Genomic Sequencing Services
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
SIC
Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Nanopore sequencing services
  • Long-read genomic analysis
  • Bioinformatics pipelines
  • Hereditary cancer panels
  • Structural variant detection

Where LongSeq is headquartered

Location

Headquarters

HQ city
Murcia
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

LongSeq business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Sequencing Services: Comprehensive genetic study, sequencing, and diagnosis services including whole genome sequencing, targeted region sequencing (PCR and enrichment), RNA sequencing, metagenomics, de novo assembly, tandem repeats analysis, plasmid sequencing, hereditary cancer sequencing, and retrotransposon analysis. Pricing is quote-based with payment terms of 30 days and 25% advance payment required for services over 5,000 euros.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProfessional sequencing services - quote-based pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

LongSeq product offering

Product offering

Core offering

LongSeq is a service provider offering comprehensive nanopore-based genetic sequencing and bioinformatics analysis using Oxford Nanopore Technologies' long-read platform. Services span whole genome sequencing, targeted region analysis (PCR and enrichment), RNA sequencing, metagenomics, de novo assembly, tandem repeat analysis, plasmid sequencing, hereditary cancer panels, and retrotransposon analysis, delivered end-to-end from study design advice to library preparation and data interpretation.

Product overview

LongSeq is a comprehensive and personalised nanopore sequencing service provider, built on Oxford Nanopore Technologies' long-read sequencing platform. The company offers a portfolio of 10 core genomic sequencing services spanning whole genome sequencing (Genomic), targeted region analysis via PCR and enrichment, RNA sequencing, metagenomics, de novo assembly, tandem repeat analysis, plasmid sequencing (Plasmi-seq), hereditary cancer panels (Hereditary-Cancer-Seq), and retrotransposon analysis (RetroSeq). Services are delivered through an end-to-end model from sample preparation advice through library preparation to bioinformatics analysis. An add-on tertiary analysis module (LongSeq + SeqOne) integrates SeqOne's AI-powered variant analysis platform for enhanced variant filtering and prioritization.

Differentiator

Problem solved

Functional benefit

Products and services

  • Genomic (Whole Genome Sequencing) Whole genome sequencing service (human, plant, animal, bacterial) using MinION, GridION, or PromethION devices, producing ultra-long reads from unmanipulated material for structural variant characterization, complex variant identification, epigenetic modification detection, and haplotype determination. Targeted at biomedical researchers, clinical researchers, and agricultural/veterinary scientists with cases that short-read sequencing cannot resolve.
  • Targeted Region (PCR) Sequencing of PCR products without fragmentation, enabling high-depth analysis with multiplexed samples to reduce cost. Applications include biallelic mutation studies, low-frequency SNP analysis, haplotype studies, and CRISPR-Cas9 cleavage evaluation. Targeted at researchers performing targeted genetic studies at high depth.
  • Targeted Region (Enrichment) Real-time sequencing directed to genomic regions of interest up to 3 Mb without DNA manipulation, achieving greater depth of coverage in the desired region. Supports biallelic mutations, low-frequency SNP analysis, haplotype studies, and population studies. Aimed at researchers needing targeted depth without amplification steps.
  • RNA Sequencing Direct sequencing of whole transcript reads using ultra-long reads of native RNA or cDNA without fragmentation or amplification. Enables characterization of complete transcripts, splicing variants, fusion genes, new isoforms, epitranscriptomic modifications, antisense transcripts, and lncRNA isoforms. Targeted at researchers requiring full-length transcript analysis.
  • Metagenomics 16S Complete 16S rRNA gene sequencing enabling accurate identification of closely related species, full transcriptomic analysis of microbial RNA, real-time species identification, microbial resistance, and virulence factor determination. Aimed at veterinary, agri-food, and biomedical researchers studying microbial communities.
  • De Novo Assembly De novo genome assembly from short reads provided by the client using standard genomic library preparation and a specific computational pipeline. Recommended for small genomes. Targeted at researchers needing reference-free genome assembly for novel organisms.
  • Tandem Repeats Analysis

Quantifiable outcome

  • Average read length of 10Kb in whole genome sequencing
  • +3 more outcomes

Companies that use LongSeq

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

LongSeq technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature8 records

LongSeq partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Oxford Nanopore TechnologiescoreTechnology or IntegrationLongSeq is an official service provider of Oxford Nanopore Technologies. They use state-of-the-art nanopore sequencing technology capable of solving complex genetic cases. The company uses Oxford Nanopore consumables and devices for all analyses, including MinION, GridION, and PromethION instruments.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

LongSeq competitors and assessment

Company assessment

Others

  • SeqOne Genomics: SeqOne is an AI-powered tertiary analysis platform for clinical genomics — LongSeq's announced technology partner (June 2026) for variant interpretation. It is an enabling/ecosystem partner whose platform LongSeq bundles into its service, not a directly competing sequencing service.
  • Oxford Nanopore Technologies: Oxford Nanopore Technologies is the platform provider that supplies LongSeq's devices and consumables, while also operating direct-service offerings (e.g., the Oxford Nanopore community of service providers). It is an upstream enabling partner and adjacent commercial actor rather than a direct customer-facing service peer.
  • VarSome (Saphetor): VarSome (Saphetor) is a clinical genomics variant interpretation platform and a listed LongSeq collaborator. It is an enabling/ecosystem adjacent entity rather than a competing sequencing service, providing the bioinformatics interpretation layer used in LongSeq's hereditary cancer workflow.

Broad incumbents

  • Eurofins Genomics: Eurofins Genomics is a global, scale sequencing services arm of Eurofins Scientific offering Sanger, NGS, and long-read services with broad bioinformatics support. It is a broad incumbent peer operating across the same genomic sequencing space as LongSeq but with much broader geographic reach, menu, and scale.
  • Novogene Europe: Novogene is a global NGS service provider with significant European operations offering WGS, RNA-seq, and custom panels at scale. It is a broad incumbent peer whose commoditized pricing power in standard sequencing services represents LongSeq's main competitive threat.

Regional players

  • Genomics and Bioinformatics Service (IMIB): IMIB (Instituto Murciano de Investigación Biosanitaria) in Murcia operates a sequencing core facility that closely overlaps with LongSeq's institutional roots and customer base. It functions as a regional peer — both serve biomedical researchers around the Murcia region — but on a non-commercial basis.

Direct peers

  • SeqCenter: SeqCenter is an Oxford Nanopore-promoted, US-based nanopore sequencing services provider offering whole-genome, amplicon, and targeted sequencing. It is a direct peer delivering equivalent ONT-based sequencing services to research customers, differing mainly by serving a US/EU customer base rather than Spain-centric.
  • Plasmidsaurus: Plasmidsaurus is a nanopore sequencing service provider specializing in plasmid verification — the same Plasmi-seq service LongSeq offers. It is a direct peer in the long-read, mid-throughput end of the nanopore services market, targeting similar molecular biology researchers.
  • FASTERIS SA: FASTERIS is a Swiss DNA sequencing services provider offering Sanger, NGS, and long-read sequencing including nanopore. It is a direct European peer to LongSeq with similar service breadth across genomic and targeted sequencing, and comparable academic/research customer base.
  • CEGAT GmbH: CEGAT is a Tübingen-based sequencing services provider covering targeted panels, exomes, and genomes with clinical-grade certifications. It is a direct European peer to LongSeq in clinical genomics service delivery, with overlapping customer types (hospitals, research groups, rare disease diagnostics).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

LongSeq social profiles

Digital presence

LongSeq compliance and trust

Trust signal

Compliance1 record

LongSeq financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LongSeq leadership team

Management profile

Number of profiles

Profiles10 records

LongSeq funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LongSeq M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LongSeq

What does LongSeq do?

LongSeq is a service provider offering comprehensive nanopore-based genetic sequencing and bioinformatics analysis using Oxford Nanopore Technologies' long-read platform. Services span whole genome sequencing, targeted region analysis (PCR and enrichment), RNA sequencing, metagenomics, de novo assembly, tandem repeat analysis, plasmid sequencing, hereditary cancer panels, and retrotransposon analysis, delivered end-to-end from study design advice to library preparation and data interpretation.

Is LongSeq a public or private company?

LongSeq is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LongSeq founded?

LongSeq was founded in 2020. It employs 1 to 10 people.

Where is LongSeq based?

LongSeq is headquartered in Murcia, Spain, in the Europe region.

How does LongSeq make money?

One revenue line is on record: sequencing Services.

Who are LongSeq's main competitors?

Others on record are SeqOne Genomics, Oxford Nanopore Technologies and VarSome (Saphetor). Broad incumbents are Eurofins Genomics and Novogene Europe. Genomics and Bioinformatics Service (IMIB) is listed as a regional player. Direct peers are SeqCenter, Plasmidsaurus, FASTERIS SA and CEGAT GmbH.

Does LongSeq have an API?

No public API is recorded for LongSeq.

What industry is LongSeq in?

LongSeq's product category is Genomic Sequencing Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5182 and its SIC code is 7374.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales